Meridian Bioscience (VIVO) Acquires EUPROTEIN

Go back to Meridian Bioscience (VIVO) Acquires EUPROTEIN

Meridian Acquires EUPROTEIN to Further Expand Recombinant Protein Capabilities

May 2, 2022 8:47 AM EDT

CINCINNATI, Ohio, May 2, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has acquired, through its subsidiary Meridian Life Science, Inc., substantially all of the assets of EUPROTEIN Inc.  The transaction closed on April 30, 2022.

... More